摘要
No AccessJournal of UrologyAdult Urology1 Jan 2015Preoperatively Misclassified, Surgically Removed Benign Renal Masses: A Systematic Review of Surgical Series and United States Population Level Burden Estimate David C. Johnson, Josip Vukina, Angela B. Smith, Anne-Marie Meyer, Stephanie B. Wheeler, Tzy-Mey Kuo, Hung-Jui Tan, Michael E. Woods, Mathew C. Raynor, Eric M. Wallen, Raj S. Pruthi, and Matthew E. Nielsen David C. JohnsonDavid C. Johnson Department of Urology, University of North Carolina, Chapel Hill, North Carolina , Josip VukinaJosip Vukina Department of Urology, University of North Carolina, Chapel Hill, North Carolina , Angela B. SmithAngela B. Smith Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Anne-Marie MeyerAnne-Marie Meyer Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Stephanie B. WheelerStephanie B. Wheeler Department of Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Tzy-Mey KuoTzy-Mey Kuo Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Hung-Jui TanHung-Jui Tan Department of Urology, Robert Wood Johnson Clinical Scholars Program, University of California-Los Angeles, Los Angeles, California , Michael E. WoodsMichael E. Woods Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Mathew C. RaynorMathew C. Raynor Department of Urology, University of North Carolina, Chapel Hill, North Carolina , Eric M. WallenEric M. Wallen Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , Raj S. PruthiRaj S. Pruthi Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina , and Matthew E. NielsenMatthew E. Nielsen University of North Carolina, Chapel Hill, North Carolina View All Author Informationhttps://doi.org/10.1016/j.juro.2014.07.102AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail Abstract Purpose: A significant proportion of renal masses removed for suspected malignancy are histologically benign with the probability inversely proportional to lesion size. To our knowledge the number of preoperatively misclassified benign renal masses treated with nephrectomy is currently unknown. Given the increasing incidence and decreasing average size of renal cell carcinoma, this burden is likely increasing. We estimated the population level burden of surgically removed, preoperatively misclassified benign renal masses in the United States. Materials and Methods: We systematically reviewed the literature for studies of pathological findings of renal masses removed for suspected renal cell carcinoma based on preoperative imaging through July 1, 2014. We excluded studies that did not describe benign pathology and with masses not stratified by size, and in which pathology results were based on biopsy. SEER data were queried for the incidence of surgically removed renal cell carcinomas in 2000 to 2009. Results: A total of 19 studies of tumor pathology based on size met criteria for review. Pooled estimates of the proportion of benign histology in our primary analysis (American studies only and 1 cm increments) were 40.4%, 20.9%, 19.6%, 17.2%, 9.2% and 6.4% for tumors less than 1, 1 to less than 2, 2 to less than 3, 3 to less than 4, 4 to 7 and greater than 7, respectively. The estimated number of surgically resected benign renal masses in the United States from 2000 to 2009 increased by 82% from 3,098 to 5,624. Conclusions: These estimates suggest that the population level burden of preoperatively misclassified benign renal masses is substantial and increasing rapidly, paralleling increases in surgically resected small renal cell carcinoma. This study illustrates an important and to our knowledge previously unstudied dimension of overtreatment that is not directly quantified in contemporary surveillance data. References 1 SEER Cancer Statistics Review, 1975–2007, updated 2010. Available at http://seer.cancer.gov/csr/1975_2007/. Accessed July 22, 2014. Google Scholar 2 : Rising incidence of renal cell cancer in the United States. JAMA1999; 281: 1628. Crossref, Medline, Google Scholar 3 : Increasing incidence of all stages of kidney cancer in the last 2 decades in the United States: an analysis of surveillance, epidemiology and end results program data. J Urol2002; 167: 57. Link, Google Scholar 4 : Utilization of radiology services in the United States: levels and trends in modalities, regions, and populations. Radiology2005; 234: 824. Google Scholar 5 : Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst2006; 98: 1331. Google Scholar 6 : Increased incidence of serendipitously discovered renal cell carcinoma. Urology1998; 51: 203. Crossref, Medline, Google Scholar 7 : Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol2000; 163: 426. Link, Google Scholar 8 : The evolving presentation of renal carcinoma in the united states: trends from the surveillance, epidemiology, and end results program. J Urol2006; 176: 2397. Link, Google Scholar 9 : Decreasing size at diagnosis of stage 1 renal cell carcinoma: analysis from the national cancer data base, 1993 to 2004. J Urol2008; 179: 2131. Link, Google Scholar 10 : Renal cell cancer stage migration: Analysis of the national cancer data base. Cancer2008; 113: 78. Google Scholar 11 : Effect of renal cancer size on the prevalence of metastasis at diagnosis and mortality. J Urol2009; 181: 1020. Link, Google Scholar 12 : Overdiagnosis in cancer. J Natl Cancer Inst2010; 102: 605. Google Scholar 13 : Guideline for management of the clinical stage T1 renal mass. J Urol2009; 182: 1271. Link, Google Scholar 14 : EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol2010; 58: 398. Google Scholar 15 : NCCN clinical practice guidelines in oncology: kidney cancer. J Natl Compr Canc Netw2009; 7: 618. Google Scholar 16 : Solid renal tumors: an analysis of pathological features related to tumor size. J Urol2003; 170: 2217. Link, Google Scholar 17 Surveillance, Epidemiology, and End Results Program: Cancer Statistics Review, 1975-2009. Based on November 2011 SEER data submission, released April 2012. Available at http://seer.cancer.gov/csr/1975_2009. Accessed July 22, 2014. Google Scholar 18 : Histopathology of surgically managed renal tumors: analysis of a contemporary series. Urology2003; 62: 827. Google Scholar 19 : Pathological features of renal neoplasms classified by size and symptomatology. J Urol2006; 176: 1317. Link, Google Scholar 20 : Incidence of benign pathologic findings at partial nephrectomy for solitary renal mass presumed to be renal cell carcinoma on preoperative imaging. Urology2006; 68: 737. Google Scholar 21 : Frequency of benign renal cortical tumors and histologic subtypes based on size in a contemporary series: what to tell our patients. J Endourol2007; 21: 819. Google Scholar 22 : Increasing detection rate of benign renal tumors: evaluation of factors predicting for benign tumor histologic features during past two decades. Urology2009; 73: 1293. Google Scholar 23 : Tumor size is associated with malignant potential in renal cell carcinoma cases. J Urol2009; 181: 2033. Link, Google Scholar 24 : Clinical predictors of renal mass pathological features. BJU Int2011; 107: 735. Google Scholar 25 : Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol2007; 178: 414. Link, Google Scholar 26 : Incidence of benign pathologic lesions at partial nephrectomy for presumed RCC renal masses: Japanese dual-center experience with 176 consecutive patients. Urology2008; 72: 598. Google Scholar 27 : Prognostic variables to predict cancer-related death in incidental renal tumours. BJU Int2008; 102: 1376. Google Scholar 28 : Incidence of benign lesions according to tumor size in solid renal masses. Int Braz J Urol2009; 35: 427. Google Scholar 29 : A multi-institutional study on histopathological characteristics of surgically treated renal tumors: the importance of tumor size. Yonsei Med J2008; 49: 639. Google Scholar 30 : A decade of surgically removed small renal masses in the Netherlands: characteristics and trends in type of surgery and pathologic reporting. J Endourol2010; 24: 1675. Google Scholar © 2015 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsCited byButaney M, Wilder S, Patel A, Qi J, Mirza M, Noyes S, Johnson A, Van Til M, Jafri S, Ginsburg K, Rogers C and Lane B (2023) Initial Management of Indeterminate Renal Lesions in a Statewide Collaborative: A MUSIC-KIDNEY AnalysisJournal of Urology, VOL. 210, NO. 1, (79-87), Online publication date: 1-Jul-2023.Su Z, Patel H, Huang M, Alam R, Cheaib J, Pavlovich C, Allaf M and Pierorazio P (2022) Active Surveillance versus Immediate Intervention for Small Renal Masses: A Cost-Effectiveness and Clinical Decision AnalysisJournal of Urology, VOL. 208, NO. 4, (794-803), Online publication date: 1-Oct-2022.Uhlig A, Lenis A, Wang X and Shuch B (2021) Sequencing of Renal Mass Biopsy and Ablation: Results from the National Cancer DatabaseUrology Practice, VOL. 8, NO. 5, (555-564), Online publication date: 1-Sep-2021.Laguna M (2019) Re: Diagnostic Needle Biopsies in Renal Masses: Patient and Physician PerspectivesJournal of Urology, VOL. 202, NO. 1, (28-29), Online publication date: 1-Jul-2019.Laguna M (2018) Re: Diagnostic Performance and Interreader Agreement of a Standardized MR Imaging Approach in the Prediction of Small Renal Mass HistologyJournal of Urology, VOL. 200, NO. 6, (1161-1162), Online publication date: 1-Dec-2018.Zhao C, Tolkach Y, Schmidt D, Kristiansen G, Müller S and Ellinger J (2017) 5′-tRNA Halves are Dysregulated in Clear Cell Renal Cell CarcinomaJournal of Urology, VOL. 199, NO. 2, (378-383), Online publication date: 1-Feb-2018.Wolf J (2017) Biopsy of Small Renal Masses Should be Routinely Performed before Deciding TreatmentJournal of Urology, VOL. 198, NO. 4, (757-759), Online publication date: 1-Oct-2017.Laviana A, Kundavaram C, Tan H, Burke M, Niedzwiecki D, Lee R and Hu J (2016) Determining the True Costs of Treating Small Renal Masses Using Time Driven, Activity Based CostingUrology Practice, VOL. 3, NO. 3, (180-186), Online publication date: 1-May-2016.Patel H, Johnson M, Pierorazio P, Sozio S, Sharma R, Iyoha E, Bass E and Allaf M (2016) Diagnostic Accuracy and Risks of Biopsy in the Diagnosis of a Renal Mass Suspicious for Localized Renal Cell Carcinoma: Systematic Review of the LiteratureJournal of Urology, VOL. 195, NO. 5, (1340-1347), Online publication date: 1-May-2016. Volume 193 Issue 1 January 2015 Page: 30-35 Supplementary Materials Advertisement Copyright & Permissions© 2015 by American Urological Association Education and Research, Inc.Keywordskidneycarcinomarenal cellneoplasmsdiagnostic errorsSEER programAcknowledgmentsMickey Kalavsky assisted with the figures. Karen Crowell assisted with the literature review.Metrics Author Information David C. Johnson Department of Urology, University of North Carolina, Chapel Hill, North Carolina More articles by this author Josip Vukina Department of Urology, University of North Carolina, Chapel Hill, North Carolina More articles by this author Angela B. Smith Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Anne-Marie Meyer Department of Epidemiology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Stephanie B. Wheeler Department of Health Policy and Management, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Tzy-Mey Kuo Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Hung-Jui Tan Department of Urology, Robert Wood Johnson Clinical Scholars Program, University of California-Los Angeles, Los Angeles, California More articles by this author Michael E. Woods Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina Financial interest and/or other relationship with LBS LabCorp. More articles by this author Mathew C. Raynor Department of Urology, University of North Carolina, Chapel Hill, North Carolina Financial interest and/or other relationship with Intuitive Surgical and Teleflex Medical. More articles by this author Eric M. Wallen Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Raj S. Pruthi Department of Urology, University of North Carolina, Chapel Hill, North Carolina Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, North Carolina More articles by this author Matthew E. Nielsen University of North Carolina, Chapel Hill, North Carolina Financial interest and/or other relationship with Best Doctors and American College of Physicians. More articles by this author Expand All Advertisement PDF downloadLoading ...